239 related articles for article (PubMed ID: 31002873)
1. Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer.
Salvi S; Bonafè M; Bravaccini S
Semin Cancer Biol; 2020 Feb; 60():132-137. PubMed ID: 31002873
[TBL] [Abstract][Full Text] [Related]
2. Estrogen Receptor Positive Breast Cancer with High Expression of Androgen Receptor has Less Cytolytic Activity and Worse Response to Neoadjuvant Chemotherapy but Better Survival.
Okano M; Oshi M; Butash AL; Asaoka M; Katsuta E; Peng X; Qi Q; Yan L; Takabe K
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151151
[TBL] [Abstract][Full Text] [Related]
3. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
4. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
Liu D
Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
[TBL] [Abstract][Full Text] [Related]
5. The effect of androgen receptor expression on clinical characterization of metastatic breast cancer.
Kim JY; Park K; Lee E; Jung HH; Ahn JS; Im YH; Park WY; Park YH
Oncotarget; 2017 Jan; 8(5):8693-8706. PubMed ID: 28060723
[TBL] [Abstract][Full Text] [Related]
6. Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer.
Huang R; Han J; Liang X; Sun S; Jiang Y; Xia B; Niu M; Li D; Zhang J; Wang S; Wei W; Liu Q; Zheng W; Zhang G; Song Y; Panga D
Cell Physiol Biochem; 2017; 43(6):2212-2225. PubMed ID: 29069648
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights.
Anestis A; Zoi I; Papavassiliou AG; Karamouzis MV
Molecules; 2020 Jan; 25(2):. PubMed ID: 31952272
[TBL] [Abstract][Full Text] [Related]
8. ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.
Fleyshman D; Cheney P; Ströse A; Mudambi S; Safina A; Commane M; Purmal A; Morgan K; Wang NJ; Gray J; Spellman PT; Issaeva N; Gurova K
Cell Cycle; 2016; 15(3):455-70. PubMed ID: 26694952
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?
Bronte G; Rocca A; Ravaioli S; Puccetti M; Tumedei MM; Scarpi E; Andreis D; Maltoni R; Sarti S; Cecconetto L; Fedeli A; Pietri E; De Simone V; Asioli S; Amadori D; Bravaccini S
BMC Cancer; 2018 Mar; 18(1):348. PubMed ID: 29587674
[TBL] [Abstract][Full Text] [Related]
10. Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.
Kurozumi S; Joseph C; Raafat S; Sonbul S; Kariri Y; Alsaeed S; Pigera M; Alsaleem M; Nolan CC; Johnston SJ; Aleskandarany MA; Ogden A; Fujii T; Shirabe K; Martin SG; Alshankyty I; Mongan NP; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2019 Jul; 176(1):63-73. PubMed ID: 30941650
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer.
Liu WJ; Zhao G; Zhang CY; Yang CQ; Zeng XB; Li J; Zhu K; Zhao SQ; Lu HM; Yin DC; Lin SX
J Cell Biochem; 2020 Apr; 121(4):2756-2769. PubMed ID: 31693255
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor in estrogen receptor positive breast cancer: Beyond expression.
Basile D; Cinausero M; Iacono D; Pelizzari G; Bonotto M; Vitale MG; Gerratana L; Puglisi F
Cancer Treat Rev; 2017 Dec; 61():15-22. PubMed ID: 29078133
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of PDEF factor expression and its relation to androgen receptor in ER
Cao L; Li C; Xu C; Xiang G; Liu F; Liu X; Jiao J; Lv S; Niu Y
Histopathology; 2018 Nov; 73(5):819-831. PubMed ID: 29969155
[TBL] [Abstract][Full Text] [Related]
14. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis.
Lu C; Yang Y; Lingmei L; Qiujuan H; Qianru G; Lisha Q; Wenfeng C; Yun N; Peisen Z
Breast Cancer Res Treat; 2023 Jan; 197(1):71-82. PubMed ID: 36334189
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes.
Shukla N; Shah K; Rathore D; Soni K; Shah J; Vora H; Dave H
Life Sci; 2024 Jul; 348():122697. PubMed ID: 38710280
[TBL] [Abstract][Full Text] [Related]
17. Androgen Receptor in Breast Cancer: From Bench to Bedside.
Chen M; Yang Y; Xu K; Li L; Huang J; Qiu F
Front Endocrinol (Lausanne); 2020; 11():573. PubMed ID: 32982970
[TBL] [Abstract][Full Text] [Related]
18. Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report.
Takuwa H; Tsuji W; Shintaku M; Yotsumoto F
BMC Cancer; 2018 Dec; 18(1):1282. PubMed ID: 30577860
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of prolactin receptor expression in breast cancer subtypes].
Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of NR3C4 in breast cancer through a genomic network understanding.
Song Y; Huang R; Wu S; Zheng H; Guo M; Fu L; Yu S
Pathol Res Pract; 2021 Jan; 217():153310. PubMed ID: 33348168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
